German company Cevec Pharmaceuticals has signed an agreement with NewLink Genetics for the use of its CAPGT and CAPGo cell lines in the development and commercialisation of products to treat Zika virus infections.

Under the agreement, NewLink Genetics and its affiliates will get the rights from Cevec to research, develop, manufacture and commercialise Zika vaccine candidates derived from the two cell lines.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Cevec CEO Frank Ubags said: “The joint agreement is a strong endorsement of our CAP system and represents another important step towards establishing Cevec’s technologies as the new global industry standard for viral vector and vaccine development.

“Outstanding yields, scalability, excellent documentation and regulatory status, including a referenceable US FDA Biologics Master File increasingly convince the biopharmaceutical industry to embark on the CAP technologies.

“We’re proud and excited to see our technologies significantly contributing to the development of a steadily growing number of innovative gene therapy and vaccine applications, including a vaccine solution that will address the threat of Zika virus disease.”

See Also:

"We’re proud and excited to see our technologies significantly contributing to the development of a steadily growing number of innovative gene therapy and vaccine applications."

The Zika infection causes no or only mild symptoms that are similar to a very mild form of dengue fever in adults and can spread from a pregnant woman to foetus.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This can result in microcephaly, brain malformations, and may also lead to other severe foetal birth defects.

The virus is spread by daytime-active Aedes mosquitoes and can also be transmitted from men and women to their sexual partners.

CAPGT suspension cell lines grow to high-cell densities and show a viral propagation spectrum.

CAPGo comprises a portfolio of glyco-optimised human suspension cell lines for the production of a range of recombinant proteins.